Our results showed that the phosphorylation level of mTOR in CD19+ B cells from women with PCOS was significantly higher compared with control subjects; and rapamycin markedly inhibited TNF-α expression in B cells from women with PCOS. The gene discussed is MTOR; the disease is polycystic ovary syndrome.